Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for optimizing treatment outcomes.

Elyce L Jones Freeman1

  • 1Independence Blue Cross, 1700 Market St. 12th Floor, Philadelphia, PA 19103, USA.

Journal of Managed Care Pharmacy : JMCP
|November 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Should eligibility for medication therapy management be based on drug adherence?

Journal of managed care pharmacy : JMCP·2014
Same journal

Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.

Journal of managed care pharmacy : JMCP·2014
Same journal

Pharmacists' role in the care of patients with heart failure: review and future evolution.

Journal of managed care pharmacy : JMCP·2014
Same journal

PCMHs, ACOs, and medication management: lessons learned from early research partnerships.

Journal of managed care pharmacy : JMCP·2014
Same journal

Adherence to national recommendations for safe methotrexate dispensing in community pharmacies.

Journal of managed care pharmacy : JMCP·2014
Same journal

Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.

Journal of managed care pharmacy : JMCP·2014

Lowering high cholesterol significantly reduces the risk of coronary heart disease (CHD) and related mortality. Evidence shows cholesterol reduction can decrease overall mortality and cardiovascular events by up to 35%.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Lipid Metabolism

Background:

  • Established epidemiological and prospective trials link high cholesterol to increased coronary heart disease (CHD) risk.
  • Numerous studies confirm that lowering blood cholesterol levels effectively reduces CHD risk.

Purpose of the Study:

  • To review evidence demonstrating cholesterol reduction's impact on CHD risk.
  • To discuss current and emerging treatment modalities for lipid management.
  • To outline strategies for healthcare practitioners to improve lipid treatment outcomes and patient education.

Main Methods:

  • Review of epidemiological data and prospective clinical trials.
  • Analysis of evidence supporting cholesterol reduction's efficacy.

Related Experiment Videos

  • Discussion of treatment modalities and patient-centered care strategies.

    • Main Results:

    • Cholesterol reduction is associated with up to a 35% decrease in total mortality, coronary mortality, and CHD-related events.
    • Evidence supports the benefit of lipid-lowering interventions in preventing cardiovascular events.
    • Effective patient education and practitioner strategies can enhance treatment adherence and outcomes.

    Conclusions:

    • Cholesterol reduction is a proven strategy for decreasing coronary heart disease risk and improving patient survival.
    • Comprehensive management involving treatment modalities and patient empowerment is crucial for cardiovascular risk reduction.
    • Healthcare providers play a key role in optimizing lipid management and patient engagement.